Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 15, 2020

SELL
$72.92 - $102.01 $4.5 Million - $6.3 Million
-61,760 Closed
0 $0
Q2 2020

Jul 22, 2020

SELL
$55.75 - $92.75 $4.17 Million - $6.94 Million
-74,800 Reduced 54.77%
61,760 $5.37 Million
Q1 2020

May 04, 2020

SELL
$37.9 - $104.44 $1.64 Million - $4.52 Million
-43,325 Reduced 24.08%
136,560 $7.92 Million
Q4 2019

Feb 04, 2020

BUY
$77.66 - $99.74 $926,872 - $1.19 Million
11,935 Added 7.11%
179,885 $16.6 Million
Q3 2019

Nov 14, 2019

BUY
$90.37 - $122.49 $919,966 - $1.25 Million
10,180 Added 6.45%
167,950 $15.2 Million
Q2 2019

Aug 22, 2019

SELL
$89.51 - $118.04 $16.2 Million - $21.4 Million
-180,885 Closed
0 $0
Q1 2019

Apr 15, 2019

SELL
$61.98 - $96.5 $2.15 Million - $3.34 Million
-34,615 Reduced 16.06%
180,885 $15.7 Million
Q4 2018

Feb 08, 2019

SELL
$56.04 - $82.66 $1.64 Million - $2.42 Million
-29,270 Reduced 11.96%
215,500 $13.6 Million
Q3 2018

Oct 29, 2018

BUY
$48.29 - $80.6 $1.45 Million - $2.41 Million
29,930 Added 13.93%
244,770 $19.3 Million
Q2 2018

Jul 26, 2018

SELL
$37.84 - $69.96 $2.23 Million - $4.13 Million
-59,060 Reduced 21.56%
214,840 $12.8 Million
Q1 2018

May 03, 2018

SELL
$39.82 - $57.53 $1.03 Million - $1.49 Million
-25,985 Reduced 8.66%
273,900 $11 Million
Q4 2017

Feb 06, 2018

SELL
$46.49 - $60.51 $4.58 Million - $5.96 Million
-98,485 Reduced 24.72%
299,885 $15.8 Million
Q3 2017

Nov 02, 2017

BUY
$37.05 - $47.12 $14.8 Million - $18.8 Million
398,370
398,370 $18.8 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.73B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Hodges Capital Management Inc. Portfolio

Follow Hodges Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hodges Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hodges Capital Management Inc. with notifications on news.